$MCOA #SuperBowl promotion of #hempSMART™ Brain and

New Post Public Reply Private Reply Replies (0) Message Board
TradeForProfits
405
$MCOA #SuperBowl promotion of #hempSMART™ Brain and #hempSMART™ Pain Cream :

https://finance.yahoo.com/news/marijuana-comp...00911.html

Marijuana Company of America’s hempSMART CBD Products Promoted at Super Bowl LIII
GlobeNewswire•February 5, 2019
ESCONDIDO, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (MCOA), an innovative hemp and cannabis corporation, is pleased to announce that its wholly owned subsidiary hempSMART™ attended special promotional events for its CBD infused product line during Super Bowl LIII this past weekend. The events included Ray Lewis’s “Ray of Hope” Foundation’s Gold Jacket for a Purpose event, and a special presentation at the Ice Box Club in Atlanta.

A number of professional athletes, NFL coaches, actors, musicians and other persons of interest attended the events and were given samples of the Company’s hempSMART branded products, including hempSMART™ Brain and hempSMART™ Pain Cream.

Some of the notable attendees were Ray Lewis, Deion Sanders, Andre Reed, Marshawn Lynch, Tyreek Hill, Larry Fitzgerald, Terrell Owens, Candance Parker, Jon Stewart, Andre Reed, Quincy Jones, Malcolm Jenkins, Von Miller, Brandon Marshall, Eddie George, Adrian Peterson, Maroon 5, and the Backstreet Boys.

CEO of MCOA, Donald Steinberg, stated, “Attending the Super Bowl LIII events this past weekend provided a great opportunity for well-known professional athletes and celebrities to discover how amazing and beneficial our products can be for them. MCOA anticipates that the Company will receive added exposure and an increase in brand awareness by exposing well-known individuals to our products.”

MCOA is looking forward to continuing to obtain brand exposure through its involvement at a pre-Oscar event later this month, where the Company expects to give out hempSMART samples to several Hollywood stars.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD
The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Shareholder Deals Under Fire: PRTH, BWIN, CCC Scrutiny

Updated Category News Views 4

When Deals Leave Shareholders in the Lurch Here's the deal, folks—three companies are under scrutiny for transactions that might leave their shareholders dry while insiders make a pretty penny. Priority Technology Holdings, Inc. (NASDAQ:PRTH), Baldwin Group, Inc. (NASDAQ:BWIN), and CCC Intelligent Solutions Holdings Inc. (NASDAQ:CCC) are being probed by Halper Sadeh LLC...

Continue Reading
ASPR AI Unveils Private Sales Agent Studio

Updated Category News Views 2

Pushing Sales AI Into a Secure Future Picture a world where your most sensitive sales data stays safely behind your own digital doors. ASPR AI is shaking up the game by launching its Private Sales Agent Studio, a move that catapults enterprise sales management into a new era of control and customization. Why Private Means Business Here's the meat of it: sales AI usually...

Continue Reading
Genimous Lands a Role as an OpenAI Select Partner

Updated Category News Views 6

Genimous Teaming Up with OpenAI Genimous just got the nod from OpenAI, bagging a spot as a Select Partner. Now, if you've been paying any attention, you know OpenAI isn’t handing out partnerships like Halloween candy. Genimous got this shiny badge due to its work in digital interaction marketing. We’re talking from gaming to e-commerce, they’ve got the hands in...

Continue Reading
Shareholder Watch: VRNS, DSGR, PSNL Under Scrutiny

Updated Category News Views 5

Navigating Murky Waters: Legal Scrutiny on Shareholder Deals The financial world ain't short on drama these days, and it looks like Varonis Systems, Distribution Solutions Group, and Personalis are right in the thick of it. Each is facing scrutiny over their recent sale transactions that might not be all they’re cracked up to be. Could these deals be shortchanging...

Continue Reading
Veterinary Industry Could Unlock Growth by Empowering Technicians

Updated Category News Views 7

Doors Not Fully Open for Vet Technicians Here's the skinny: the vet industry’s sitting on a goldmine of untapped potential right under its nose. According to a fresh study by Penn Foster, there's a glaring disconnect between what vet techs are trained to handle and what they're actually allowed to do in practice. If practices start trusting these pros to do their thing,...

Continue Reading
Podium Surges Past $150M in AI ARR Milestone

Updated Category News Views 5

A New Era for Podium When the brass at Podium made a gamble on AI, they didn't just try squeezing it into their old business model. Oh no, they launched what feels like a startup within their existing empire—no half-measures, just full-throttle ambition. Fast forward two and a half years, and they've racked up over $150 million in annual recurring revenue from these...

Continue Reading
Rakuten Medical's Long-Term Data Shows Promise

Updated Category News Views 0

This Isn't Just Another Cancer Update Alright, folks, let's unwrap what's happening today with Rakuten Medical. They've thrown some serious numbers into the ring at the ESMO Congress 2026 in Madrid. We're talking long-term follow-up results of their ASP-1929 photoimmunotherapy combined with pembrolizumab in tackling recurrent and metastatic head and neck squamous cell...

Continue Reading
AuraQuantic Leads SPARK Matrix™ in 2026 IPO Ranking

Updated Category News Views 2

Not Just Another Day in Tech When tech outfits make headlines, it's often because of a shiny new gadget or some jarring security breach. Today, it's AuraQuantic getting their well-deserved spotlight, having snagged the leader's spot in the SPARK Matrix™ for Intelligent Process Orchestration (IPO). You might be wondering what makes this accolade worth attention in a...

Continue Reading
Country Stars Illuminate Art in Philly, Mississippi

Updated Category News Views 2

A Mural Tribute to Country Music Roots Forget about skyscrapers and bustling metropolises; sometimes, it's about bringing a bit of soul back to the heartland. That's precisely what the unveiling of the "Wildflowers and Wild Horses" mural in Philadelphia, Mississippi, did. Lainey Wilson and Marty Stuart's Vision Partners in crime — or, more fittingly, in country —...

Continue Reading
Haystack Expands MCP to Boost AI Intranet Workflow

Updated Category News Views 8

Bridging the Intranet and AI: A Game Changer? You ever feel like your company's intranet is a black hole, swallowing all the information you need before spitting it back out in a chaos of outdated pages and broken links? Well, Haystack aims to clear that fog with their Model Context Protocol (MCP) server. And starting October 26, the game takes a leap forward. Now, not...

Continue Reading

Top 5 Most Recently Viewed Articles

Canopy Growth Corporation Faces Class Action Lawsuit Risks

Updated Category News Views 141

Canopy Growth Corporation Faces Class Action Lawsuit Risks Levi & Korsinsky, LLP has recently alerted investors regarding Canopy Growth Corporation, a significant player in the cannabis industry. The firm is representing investors in a class action securities lawsuit aimed at recovering losses faced by those affected by alleged securities fraud. Understanding the Class...

Continue Reading
Moleculin Biotech Shares Insights on Annamycin for STS Treatment

Updated Category News Views 135

Moleculin Biotech’s Recent Developments in Soft Tissue Sarcoma Treatment Moleculin Biotech, Inc. (NASDAQ: MBRX), a prominent pharmaceutical firm, has recently unveiled an on-demand Key Opinion Leader (KOL) webcast. It covers crucial findings from their Phase 1B/2 clinical study, focused on Annamycin's efficacy as a treatment for soft tissue sarcoma (STS) lung...

Continue Reading
Battery Materials Market Growth and Key Industry Drivers

Updated Category News Views 89

Battery Materials Market Growth Prospects The battery materials market is experiencing a significant transformation as we move toward a new era of energy solutions. Fueled by the surge in electric vehicle (EV) sales and the rising need for renewable energy storage, this sector is anticipated to reach a robust valuation in the coming years. According to recent market...

Continue Reading
Iberdrola Honors Global Volunteers Making A Difference Today

Updated Category News Views 138

Back in 2024, Iberdrola threw a bash to honor its unsung heroes—employees who committed themselves to charitable causes around the globe. This wasn't just some corporate back-patting; it was a big deal that highlighted how these folks transformed lives and communities with their relentless spirit. Iberdrola Volunteer Heroes: Recognition That Matters At ScottishPower’s...

Continue Reading
Nordic Capital and Evosep Join Forces for Growth in Proteomics

Updated Category News Views 128

Nordic Capital Forms Strategic Alliance with Evosep Nordic Capital has made headlines with its recent decision to acquire a majority stake in Evosep, an innovative Danish company that specializes in sample preparation and separation solutions primarily for LC-MS-based proteomics. This strategic investment comes as Nordic Capital aims to leverage its extensive experience...

Continue Reading